{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:10:51Z","timestamp":1790964651670,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03086-x","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:15:48Z","timestamp":1770117348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing causal relationships between iron level, disorders of iron metabolism, and hepatocellular carcinoma: a Mendelian randomisation study"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8195-0339","authenticated-orcid":false,"given":"Sifan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8873-223X","authenticated-orcid":false,"given":"Xujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0846-6081","authenticated-orcid":false,"given":"Shiqi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6202-457X","authenticated-orcid":false,"given":"Yongmei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-4972","authenticated-orcid":false,"given":"An","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"3","key":"3086_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3086_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5582\/bst.2022.01061","volume":"16","author":"N Wen","year":"2022","unstructured":"Wen N, Cai Y, Li F, et al. The clinical management of hepatocellular carcinoma worldwide: a concise review and comparison of current guidelines: 2022 update. Biosci Trends. 2022;16(1):20\u201330. https:\/\/doi.org\/10.5582\/bst.2022.01061.","journal-title":"Biosci Trends"},{"issue":"5","key":"3086_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14737140.2025.2489651","volume":"25","author":"QB Wang","year":"2025","unstructured":"Wang QB, Li J, Zhang ZJ, et al. The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior Vena cave and\/or right atrium: a systematic review and single-arm meta-analysis. Expert Rev Anticancer Ther. 2025;25(5):561\u201370. https:\/\/doi.org\/10.1080\/14737140.2025.2489651.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3086_CR4","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Liang YB, Wang QB, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front Immunol. 2025;15:1519999. https:\/\/doi.org\/10.3389\/fimmu.2024.1519999. Published 2025 Jan 7.","journal-title":"Front Immunol"},{"key":"3086_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/JHC.S462168","volume":"11","author":"YK Li","year":"2024","unstructured":"Li YK, Wu S, Wu YS, et al. Portal venous and hepatic arterial coefficients predict Post-Hepatectomy overall and Recurrence-Free survival in patients with hepatocellular carcinoma: a retrospective study. J Hepatocell Carcinoma. 2024;11:1389\u2013402. https:\/\/doi.org\/10.2147\/JHC.S462168. Published 2024 Jul 9.","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"3086_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy B, Conrad M, Muckenthaler M. Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol. 2024;25(2):133\u201355. https:\/\/doi.org\/10.1038\/s41580-023-00648-1.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"24","key":"3086_CR7","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1111\/febs.16208","volume":"289","author":"K Hino","year":"2022","unstructured":"Hino K, Yanatori I, Hara Y, Nishina S. Iron and liver cancer: an inseparable connection. FEBS J. 2022;289(24):7810\u201329. https:\/\/doi.org\/10.1111\/febs.16208.","journal-title":"FEBS J"},{"issue":"Suppl 1","key":"3086_CR8","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1111\/hdi.12542","volume":"21","author":"S Dev","year":"2017","unstructured":"Dev S, Babitt JL. Overview of iron metabolism in health and disease. Hemodial Int. 2017;21(Suppl 1):S6\u201320. https:\/\/doi.org\/10.1111\/hdi.12542.","journal-title":"Hemodial Int"},{"issue":"23\u201324","key":"3086_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00508-015-0842-3","volume":"127","author":"H Ludwig","year":"2015","unstructured":"Ludwig H, Evstatiev R, Kornek G, et al. Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr. 2015;127(23\u201324):907\u201319. https:\/\/doi.org\/10.1007\/s00508-015-0842-3.","journal-title":"Wien Klin Wochenschr"},{"issue":"12","key":"3086_CR10","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.3390\/cells9122591","volume":"9","author":"MY Hsu","year":"2020","unstructured":"Hsu MY, Mina E, Roetto A, Porporato PE. Iron: an essential element of Cancer metabolism. Cells. 2020;9(12):2591. https:\/\/doi.org\/10.3390\/cells9122591. Published 2020 Dec 3.","journal-title":"Cells"},{"issue":"1","key":"3086_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. Mendelian randomization\u2019: can genetic epidemiology contribute to Understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322. https:\/\/doi.org\/10.1093\/ije\/dyg070.","journal-title":"Int J Epidemiol"},{"key":"3086_CR12","doi-asserted-by":"publisher","first-page":"1180596","DOI":"10.3389\/fmed.2023.1180596","volume":"10","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yuan S, Li Y, et al. Atopic dermatitis and chronic kidney disease: a bidirectional Mendelian randomization study. Front Med (Lausanne). 2023;10:1180596. https:\/\/doi.org\/10.3389\/fmed.2023.1180596. Published 2023 Jun 27.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"3086_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740\u201352. https:\/\/doi.org\/10.1093\/ije\/dyq151.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"3086_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"issue":"4","key":"3086_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"3086_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"3086_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5582\/bst.2021.01094","volume":"15","author":"Y Sugawara","year":"2021","unstructured":"Sugawara Y, Hibi T. Surgical treatment of hepatocellular carcinoma. Biosci Trends. 2021;15(3):138\u201341. https:\/\/doi.org\/10.5582\/bst.2021.01094.","journal-title":"Biosci Trends"},{"issue":"3","key":"3086_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","volume":"34","author":"H Gilles","year":"2022","unstructured":"Gilles H, Garbutt T, Landrum J. Hepatocellular carcinoma. Crit Care Nurs Clin North Am. 2022;34(3):289\u2013301. https:\/\/doi.org\/10.1016\/j.cnc.2022.04.004.","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"6","key":"3086_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(13)70174-8","volume":"2","author":"JM Fern\u00e1ndez-Real","year":"2014","unstructured":"Fern\u00e1ndez-Real JM, Manco M. Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol. 2014;2(6):513\u201326. https:\/\/doi.org\/10.1016\/S2213-8587(13)70174-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"3086_CR20","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/hep.20241","volume":"39","author":"C J\u00fcngst","year":"2004","unstructured":"J\u00fcngst C, Cheng B, Gehrke R, et al. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology. 2004;39(6):1663\u201372. https:\/\/doi.org\/10.1002\/hep.20241.","journal-title":"Hepatology"},{"issue":"1","key":"3086_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jhep.2016.01.037","volume":"65","author":"A Pietrangelo","year":"2016","unstructured":"Pietrangelo A. Mechanisms of iron hepatotoxicity. J Hepatol. 2016;65(1):226\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2016.01.037.","journal-title":"J Hepatol"},{"issue":"4","key":"3086_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-2005-923315","volume":"25","author":"GA Ramm","year":"2005","unstructured":"Ramm GA, Ruddell RG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis. 2005;25(4):433\u201349. https:\/\/doi.org\/10.1055\/s-2005-923315.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"3086_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","volume":"12","author":"B Keith","year":"2011","unstructured":"Keith B, Johnson RS, Simon MC. HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011;12(1):9\u201322. https:\/\/doi.org\/10.1038\/nrc3183. Published 2011 Dec 15.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3086_CR24","first-page":"333","volume":"21","author":"E Abd Elmonem","year":"2009","unstructured":"Abd Elmonem E, Tharwa el-S, Farag MA, Fawzy A, El Shinnawy SF, Suliman S. Hepcidin mRNA level as a parameter of disease progression in chronic hepatitis C and hepatocellular carcinoma. J Egypt Natl Canc Inst. 2009;21(4):333\u201342.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"6","key":"3086_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3181\/0807-RM-227","volume":"234","author":"MG Tan","year":"2009","unstructured":"Tan MG, Kumarasinghe MP, Wang SM, Ooi LL, Aw SE, Hui KM. Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp Biol Med (Maywood). 2009;234(6):693\u2013702. https:\/\/doi.org\/10.3181\/0807-RM-227.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"20","key":"3086_CR26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.21037\/atm-21-4608","volume":"9","author":"T Tian","year":"2021","unstructured":"Tian T, Xiao F, Li H, et al. Association between serum iron status and primary liver cancer risk: a Mendelian randomization analysis. Ann Transl Med. 2021;9(20):1533. https:\/\/doi.org\/10.21037\/atm-21-4608.","journal-title":"Ann Transl Med"},{"issue":"5","key":"3086_CR27","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/advances\/nmab035","volume":"12","author":"W Kang","year":"2021","unstructured":"Kang W, Barad A, Clark AG, et al. Ethnic differences in Iron status. Adv Nutr. 2021;12(5):1838\u201353. https:\/\/doi.org\/10.1093\/advances\/nmab035.","journal-title":"Adv Nutr"},{"issue":"3","key":"3086_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cgh.2018.05.039","volume":"17","author":"NE Rich","year":"2019","unstructured":"Rich NE, Hester C, Odewole M, et al. Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2019;17(3):551\u2013e5591. https:\/\/doi.org\/10.1016\/j.cgh.2018.05.039.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3086_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11894-004-0028-z","volume":"6","author":"J Fleckenstein","year":"2004","unstructured":"Fleckenstein J. Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep. 2004;6(1):66\u201370. https:\/\/doi.org\/10.1007\/s11894-004-0028-z.","journal-title":"Curr Gastroenterol Rep"},{"issue":"17","key":"3086_CR30","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1080\/14656566.2024.2426680","volume":"25","author":"G Catalano","year":"2024","unstructured":"Catalano G, Chatzipanagiotou OP, Kawashima J, Pawlik TM. Metabolic-associated steatotic liver disease and hepatocellular carcinoma. Expert Opin Pharmacother. 2024;25(17):2283\u201391. https:\/\/doi.org\/10.1080\/14656566.2024.2426680.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"3086_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.14218\/JCTH.2023.00356","volume":"12","author":"Y Abboud","year":"2024","unstructured":"Abboud Y, Ismail M, Khan H, et al. Hepatocellular carcinoma incidence and mortality in the USA by sex, age, and race: a nationwide analysis of two decades. J Clin Transl Hepatol. 2024;12(2):172\u201381. https:\/\/doi.org\/10.14218\/JCTH.2023.00356.","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"3086_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/nu12020526","volume":"12","author":"S Yuan","year":"2020","unstructured":"Yuan S, Carter P, Vithayathil M, et al. Iron status and Cancer risk in UK biobank: a Two-Sample Mendelian randomization study. Nutrients. 2020;12(2):526. https:\/\/doi.org\/10.3390\/nu12020526. Published 2020 Feb 19.","journal-title":"Nutrients"},{"issue":"1","key":"3086_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000343856","volume":"3","author":"MC Kew","year":"2014","unstructured":"Kew MC. Hepatic iron overload and hepatocellular carcinoma. Liver Cancer. 2014;3(1):31\u201340. https:\/\/doi.org\/10.1159\/000343856.","journal-title":"Liver Cancer"},{"issue":"1","key":"3086_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12664-013-0367-5","volume":"33","author":"PS Patil","year":"2014","unstructured":"Patil PS, Mohandas KM, Bhatia SJ. Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case-control study. Indian J Gastroenterol. 2014;33(1):12\u20138. https:\/\/doi.org\/10.1007\/s12664-013-0367-5.","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"3086_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jclinpath-2015-203215","volume":"69","author":"S Nanba","year":"2016","unstructured":"Nanba S, Ikeda F, Baba N, et al. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C. J Clin Pathol. 2016;69(3):226\u201333. https:\/\/doi.org\/10.1136\/jclinpath-2015-203215.","journal-title":"J Clin Pathol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03086-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:35:04Z","timestamp":1772620504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03086-x"}},"subtitle":["The first author"],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3086"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03086-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This human study did not require ethical review and approval, as it was conducted using summary data derived from a publicly accessible database. The data used in this study were anonymized and de-identified, ensuring that no individual participants could be identified. All analyses were performed in compliance with relevant guidelines and regulations for research involving publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to partcipate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}